Lifera, a biopharma company wholly owned by the Public Investment Fund (PIF), launched in 2023, is scaling up its subsidiary ...
In a recent study published in Nature Communications, researchers utilized a comprehensive multi-omics approach, integrating ...
Cambridge-based CardiaTec has raised $6.5mn for its AI-based drug discovery platform for cardiovascular diseases.
Aiming to reduce reliance on Western data for addressing the cancer that impacts millions in the country, India on Saturday launched its first comprehensive multi-omics cancer data portal, starting ...